Digestive Diseases and Sciences

, Volume 41, Issue 10, pp 1909–1914 | Cite as

Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy

  • Ole Suhr
  • Åke Danielsson
  • Anders Rydh
  • Nils Nyhlin
  • Sven Ola Hietala
  • Lars Steen


Liver transplantation is the only effective treatment of familial amyloidotic polyneuropathy type I (FAP). The aim of the present investigation was to identify factors at the time of submission for transplantation that had impact on survival, with special reference to gastrointestinal disturbances. All 28 liver-transplanted FAP patients evaluated at Umeå University Hospital were included in the study. A modified body mass index was used to assess nutritional status. Intestinal examinations were performed to diagnose bile acid malabsorption, gastric retention, and bacterial contamination of the small bowel. A significantly improved survival rate was found for patients in a good nutritional state (P=0.002). Peripheral neurological symptoms were unrelated to survival, whereas increased mortality was found for patients with bile acid malabsorption (P<0.05). Bacterial contamination and gastric retention were common complications of the disease. In conclusion, malabsorption and malnutrition have a profound impact on the outcome of liver transplantation for familial amyloidotic polyneuropathy.

Key words

hereditary amyloidosis inborn errors of metabolism malabsorption fat bile acids liver transplantation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andrade C: A peculiar form of peripheral neuropathy. Familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75:408–427, 1952PubMedGoogle Scholar
  2. 2.
    Andersson R: Familial amyloidosis with polyneuropathy: A clinical study based on patients living in northern Sweden. Acta Med Scand 198(suppl 590):1–64, 1976Google Scholar
  3. 3.
    Saraiva MJ, Costa PP, Birken S, Goodman DS: Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 96:261–270, 1983PubMedGoogle Scholar
  4. 4.
    Coutinho P, Martins da Silva A, Kopes Lima J, Resende Barbosa A: Forty years of experience with type I amyloid neuropathy. Review of 483 cases.In Amyloid and Amyloidosis. G Glenner, P Pinho e Costa, A Folcao de Freitas (eds). Amsterdam. Excerpta Medica, 1980, pp 88–98Google Scholar
  5. 5.
    Olofsson B-O: Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol 4:71–73, 1983PubMedGoogle Scholar
  6. 6.
    Olofsson B-O, Suhr O, Niklasson U, Wiklund U, Bjerle P, Beckman A: Assessment of autonomic nerve function in familial amyloidotic polyneuropathy: A clinical study based on spectral analysis of heart rate variability. Amyloid Int J Exp Clin Invest 1:138–142, 1994Google Scholar
  7. 7.
    Ikeda S, Yanagisawa N, Hongo M, Ito N: Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 79:129–139, 1987PubMedGoogle Scholar
  8. 8.
    Bergfeldt BL, Olofsson BO, Edhag KO: Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol 56:647–652, 1985PubMedGoogle Scholar
  9. 9.
    Steen L, Ek B: Familial amyloidosis with polyneuropathy. A long-term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 214:387–397, 1984Google Scholar
  10. 10.
    Suhr O, Danielsson Å, Holmgren G, Steen L: Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 235:479–485, 1994PubMedGoogle Scholar
  11. 11.
    Holmgren G, Ericzon B-G, Groth C-G, Steen L, Suhr O, Andersson O, Wallin B, Seymor A, Richardson S, Hawkins P, Pepys M: Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341:1113–1116, 1993PubMedGoogle Scholar
  12. 12.
    Lewis W, Skinner M, Simms R, Jones L, Cohen A, Jenkins R: Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transplant 8:107–110, 1994PubMedGoogle Scholar
  13. 13.
    Steen L, Holmgren G, Suhr O, Wikström L, Groth C-G, Ericzon BG: Worldwide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid Int J Exp Clin Invest 1:138–142, 1994Google Scholar
  14. 14.
    Suhr O, Holmgren G, Steen L, Wikström L, Nordén G, Friman S, Duraj F, Groth C-G, Ericzon B-G: Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 60:933–938, 1995PubMedGoogle Scholar
  15. 15.
    Suhr O, Holmgren G: Difficulties in clinical diagnosis and prediction of outcome in patients with transthyretin Met 30 mutation: Report of two cases. Amyloid Int J Exp Clin Invest 2:179–182, 1995Google Scholar
  16. 16.
    Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A: Familial amyloidotic polyneuropathy in Sweden: A pedigree analysis. J Med Genet 30:388–392, 1993PubMedGoogle Scholar
  17. 17.
    Holmgren G, Costa P, Andersson C, Asplund K, Steen L, Beckman L, Nylander P-O, Teixeira A, Saraiva M, Costa P: Geographical distribution of TTR met30 carriers in northern Sweden: Discrepancy between carrier frequency and prevalence rate. J Med Genet 31:351–354, 1994PubMedGoogle Scholar
  18. 18.
    Holmgren G, Holmberg E, Lindström A, Lindström E, Nordenson I, Sandgren O, Steen L, Svensson B, Lundgren E, von Gabain A: Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 33:176–180, 1988PubMedGoogle Scholar
  19. 19.
    Suhr O, Danielsson Å, Nyhlin H, Truedsson H: Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol 23:1187–1194, 1988PubMedGoogle Scholar
  20. 20.
    Kerlin P, Wong L: Breath hydrogen testing in bacterial over-growth of the small intestine. Gastroenterology 95:982–988, 1988PubMedGoogle Scholar
  21. 21.
    van de Kamer J, Huinink B, Ten B, Weyers H: Rapid method for the determination of fat in faeces. J Biol Chem 177:347–355, 1947Google Scholar
  22. 22.
    Suhr O, Danielsson Å, Steen L, Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy. Scand J Gastroenterol 27:201–207, 1992PubMedGoogle Scholar
  23. 23.
    El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L: Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 35:1413–1418, 1994PubMedGoogle Scholar
  24. 24.
    El-Salhy M, Suhr O: Endocrine cells in rectal biopsies from patients with familial amyloidotic polyneuropathy. Scand J Gastroenterol 31:68–73, 1996PubMedGoogle Scholar
  25. 25.
    Suhr O, Danielsson Å, Hörstedt P, Stenling R: Bacterial contamination of the small bowel evaluated by breath tests,75Selabeled homocholic tauro acid and scanning electron microscopy. Scand J Gastroenterol 25:841–852, 1990PubMedGoogle Scholar
  26. 26.
    King CE, Toskes PP: Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 91:1447–1451, 1986PubMedGoogle Scholar
  27. 27.
    Gorazza G, Menozzi M, Strocchi A, Rasciti L, Vaira D, Lecchini R, Avanzini P, Chezzi C, Gasbarrini G: The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 98:302–309, 1990PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Ole Suhr
    • 1
  • Åke Danielsson
    • 1
  • Anders Rydh
    • 1
  • Nils Nyhlin
    • 1
  • Sven Ola Hietala
    • 1
  • Lars Steen
    • 1
  1. 1.From the Department of Medicine, Section for Gastroenterology and Department of Diagnostic RadiologyUmeå University HospitalUmeåSweden
  2. 2.Department of Medicine, Section for Gastroenterology and HepatologyUmeå University HospitalUmeåSweden

Personalised recommendations